Siga Technologies INC

SIGA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016
Revenue $12.3M $15.0M
Cost of Revenue $0 $0
Gross Profit $12.3M $15.0M
Gross Margin 100.0% 100.0%
Operating Expenses
Research & Development $16.7M $19.7M
SG&A Expense $12.3M $13.7M
Operating Income $-18.8M $-31.0M
Operating Margin -153.6% -206.9%
Interest Expense $14.8M $2.4M
Pretax Income $-38.3M $-39.7M
Income Tax Expense $-2.1M $13.9K
Net Income $-36.2M $-39.7M
Net Margin -295.3% -264.9%
EPS (Basic) $-0.46 $-0.69
EPS (Diluted) $-0.46 $-0.69
Shares Outstanding (Basic) 78.9M 57.2M
Shares Outstanding (Diluted) 78.9M 57.2M
Dividends Per Share
← Newer Page 2 of 2 Older →